Select a day ->
Agenda – Wednesday, February 7, 2024
SPECIALTY DAY: Mental Health in Pediatrics (VIRTUAL)
All presentations will be given in English unless otherwise specified. Participants can however submit their questions in English and French.
08:00-08:30
Sign-in
08:30-08:35
Welcome and Introduction
08:35-09:20
Depression in Children and Adolescents
Johanne Renaud
Chief of Psychiatry, Child and Adolescent Psychiatrist, Douglas Mental Health
University Institute, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Recognize the signs and symptoms of depression
2. Initiate a pharmacological treatment
3. Review the psychotherapeutic options
1. Recognize the signs and symptoms of depression
2. Initiate a pharmacological treatment
3. Review the psychotherapeutic options
09:20-10:05
Warning Signs of Suicide in Children and Adolescents
Anthony Joseph Gifuni
Psychiatrist, Douglas Mental Health University Institute, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Discuss the epidemiology of suicidal risk among teenagers
2. Utilise the assessment tools in suicidal risk assessment
3. Know when to refer the patient to the ER
1. Discuss the epidemiology of suicidal risk among teenagers
2. Utilise the assessment tools in suicidal risk assessment
3. Know when to refer the patient to the ER
10:05-10:25
Stretch Break
10:25-11:10
Psychopharmacology in Autism Spectrum Disorder
Dana Tran
Child and Adolescent Psychiatrist, Fellow in Autism Spectrum Disorder, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Learning Objectives
At the end of this session, participants will be able to:
1. Understand the definition of autism spectrum disorder
2. Detect common psychiatric and behavioral comorbidities associated with autism spectrum disorder
3. Understand the recent literature on psychopharmacology treatment used in autism spectrum disorder
4. Recognize psychopharmacological recommendations and considerations to keep in mind when treating patients with ASD
1. Understand the definition of autism spectrum disorder
2. Detect common psychiatric and behavioral comorbidities associated with autism spectrum disorder
3. Understand the recent literature on psychopharmacology treatment used in autism spectrum disorder
4. Recognize psychopharmacological recommendations and considerations to keep in mind when treating patients with ASD
11:10-11:55
Understanding Anxiety in Children and Adolescents
Jean-Philippe Carmel
Psychiatrist, Montreal Children’s Hospital, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Identify contributing factors to development of anxiety disorders
2. Review diagnostic criteria of anxiety disorders
3. Initiate the proper interventions for the anxiety disorder
1. Identify contributing factors to development of anxiety disorders
2. Review diagnostic criteria of anxiety disorders
3. Initiate the proper interventions for the anxiety disorder
11:55-13:00
Lunch
13:00-13:45
Trauma-based Disorder and Its Impact on Children and Adolescents
Rachel Cardon Kronick
Clinician-Scientist, Division of Social and Transcultural Psychiatry, McGill University, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Recognize the significane of Adverse Childhood Experiences (ACE) and trauma
2. Recognize the range of stress-based disorders and clinical controversies regarding screening
3. Employ an ecosocial approach to management that draws on community, family and individual resources
1. Recognize the significane of Adverse Childhood Experiences (ACE) and trauma
2. Recognize the range of stress-based disorders and clinical controversies regarding screening
3. Employ an ecosocial approach to management that draws on community, family and individual resources
13:45-14:30
Gender Dysphoria in Childhood and Adolescence
Shuvo Ghosh
Developmental-Behavioral Pediatrician, Montreal Children’s Hospital, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Know the definition of gender dysphoria
2. Identify the youth with gender dysphoria
3. Orient the youth to proper resources
1. Know the definition of gender dysphoria
2. Identify the youth with gender dysphoria
3. Orient the youth to proper resources
14:30-14:45
Stretch Break
14:45-15:30
Approach to Eating Disorders in the Pediatric Office
Suzanne MacDonald
Pediatrician, Adolescent Medicine, Montreal Children’s Hospital, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Recognize possible presentations for the various eating disorders presenting in the pediatric age
2. Discuss how malnutrition may differentially impact children and adolescent patients versus adults patients
3. Describe concrete, actionable first steps in the management of an eating disorder patient in the office
4. Identify which patients require referral to the eating disorder program and/or an admission to a medical ward
1. Recognize possible presentations for the various eating disorders presenting in the pediatric age
2. Discuss how malnutrition may differentially impact children and adolescent patients versus adults patients
3. Describe concrete, actionable first steps in the management of an eating disorder patient in the office
4. Identify which patients require referral to the eating disorder program and/or an admission to a medical ward
15:30-16:15
Substance Use Disorders in Youth
Jennifer Picado
Psychiatrist, Department of Psychiatry, McGill University, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Review the epidemiology and clinical presentation of Substance Use Disorders in youth.
2. Outline an approach to screening and assessment.
3. Discuss treatment approaches and resources.
1. Review the epidemiology and clinical presentation of Substance Use Disorders in youth.
2. Outline an approach to screening and assessment.
3. Discuss treatment approaches and resources.
16:15-17:15
Complex Psychopharmacology for ADHD
Martin Gignac
Psychiatrist, Department of Psychiatry, Montreal Children's Hospital, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. Discuss frequent comorbidities with ADHD.
2. Explore medication combinations.
3. Evaluate the role of pharmacogenetic testing in ADHD.
1. Discuss frequent comorbidities with ADHD.
2. Explore medication combinations.
3. Evaluate the role of pharmacogenetic testing in ADHD.
17:15-17:30
Closing Remarks